Cyclooxygenase inhibition in cancer--a blind alley or a new therapeutic reality?

N Engl J Med. 2002 Apr 4;346(14):1085-7. doi: 10.1056/NEJM200204043461412.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Adenomatous Polyposis Coli / genetics
  • Adenomatous Polyposis Coli / prevention & control*
  • Adenomatous Polyps / prevention & control
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
  • Celecoxib
  • Colonic Polyps / prevention & control
  • Cyclooxygenase 2
  • Cyclooxygenase 2 Inhibitors
  • Cyclooxygenase Inhibitors / therapeutic use*
  • Genes, APC
  • Germ-Line Mutation
  • Humans
  • Isoenzymes / antagonists & inhibitors*
  • Membrane Proteins
  • Prostaglandin-Endoperoxide Synthases
  • Pyrazoles
  • Sulfonamides / therapeutic use
  • Sulindac / therapeutic use*

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Cyclooxygenase 2 Inhibitors
  • Cyclooxygenase Inhibitors
  • Isoenzymes
  • Membrane Proteins
  • Pyrazoles
  • Sulfonamides
  • Sulindac
  • Cyclooxygenase 2
  • PTGS2 protein, human
  • Prostaglandin-Endoperoxide Synthases
  • Celecoxib